FSD Pharma Inc. (HUGE) |
| 0.0899 -0.01 (-10.1%) 08-14 16:00 |
| Open: | 0.095 |
| High: | 0.1042 |
| Low: | 0.087 |
| Volume: | 22,015,006 |
| Market Cap: | 0(M) |
| PE Ratio: | -0.01 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 20.37 |
| Resistance 1: | 19.59 |
| Pivot price: | 19.40 |
| Support 1: | 18.33 |
| Support 2: | 15.25 |
| 52w High: | 109.1935 |
| 52w Low: | 0.087 |
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 08 Apr 2025
FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc. - ACCESS Newswire
Thu, 15 Aug 2024
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 Consolidation - Trading Under New Ticker Symbol "QNTM" - Stock Titan
Thu, 15 Aug 2024
Quantum BioPharma Ltd. Subordinate Voting Shares - The Canadian Securities Exchange (CSE)
Tue, 13 Aug 2024
2024-0813 – Name & Symbol Change and Consolidation - FSD Pharma Inc. Class B Subordinate Voting Shares (HUGE) - The Canadian Securities Exchange (CSE)
Fri, 09 Aug 2024
FSD Pharma Announces Share Consolidation and Name Change - Yahoo Finance
Thu, 30 Nov 2023
FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
